Azathioprine: Difference between revisions

(hepatic dosing)
(special populations)
Line 32: Line 32:


==Special Populations==
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]:
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: Pregnancy Category D
*[[Lactation risk categories|Lactation risk]]:
*[[Lactation risk categories|Lactation risk]]: possibly unsafe
===Renal Dosing===
===Renal Dosing===
*Adult: CrCl 10-50: decr. dose 25%; CrCl <10: decr. dose 50%; HD: give 0.25 mg/kg supplement; PD: not defined
*Adult: CrCl 10-50: decr. dose 25%; CrCl <10: decr. dose 50%; HD: give 0.25 mg/kg supplement; PD: not defined

Revision as of 02:45, 9 February 2016

Administration

  • Type: immunosuppressant
  • Dosage Forms: 50
  • Routes of Administration: PO (IV form unavailable in US)
  • Common Trade Names: Azasan, Imuran

Adult Dosing

Kidney transplant rejection prophylaxis

  • 1-3 mg/kg PO qd
  • Start: 3-5 mg/kg PO x1 up to 3 days before transplant; Info: transplant protocols may vary

Rheumatoid arthritis, severe

  • 1-2.5 mg/kg/day PO divided qd-bid
  • Start: 1 mg/kg/day PO divided qd-bid; Max: 2.5 mg/kg/day; Info: after 6-8wk may incr. 0.5 mg/kg/day q4wk

Crohns Disease

  • 100-250 mg PO qd
  • Start: 50 mg PO qd; Max: 2.5 mg/kg/day; Info: for induction or remission maintenance and fistulizing disease, steroid-sparing effects

Ulcerative colitis

  • 100-250 mg PO qd
  • Start: 50 mg PO qd; Max: 2.5 mg/kg/day; Info: for induction or remission maintenance, steroid-sparing effects

Pediatric Dosing

Kidney transplant rejection prophylaxis

  • 1-3 mg/kg PO qd
  • Start: 3-5 mg/kg PO x1 up to 3 days before transplant; Info: transplant protocols may vary

Juvenile idiopathic arthritis, severe

  • 1-2.5 mg/kg/day PO divided qd-bid
  • Start: 1 mg/kg/day PO divided qd-bid; Max: 2.5 mg/kg/day; Info: after 6-8wk may incr. 0.5 mg/kg/day q4wk

Special Populations

Renal Dosing

  • Adult: CrCl 10-50: decr. dose 25%; CrCl <10: decr. dose 50%; HD: give 0.25 mg/kg supplement; PD: not defined
  • Pediatric: CrCl 10-50: decr. dose 25% or give q36h; CrCl <10: decr. dose 50% or give q48h; HD: give supplement; PD: not defined

Hepatic Dosing

  • Adult: not defined; caution advised
  • Pediatric: not defined; caution advised

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:

Mechanism of Action

Comments

See Also

References